Anuja Antony

I always loved science and mathematics as a child. My summers were spent building rockets and dissecting frogs at science camp and I was fortunate to be selected to attend boarding highschool at the NC School of Science and Mathematics. Being the Chief Medical Officer at SimBioSys and pursuing a scientific career path for myself was always a natural choice for me.

John A Cole

I love solving problems; it’s what drew me into science in the first place. What is so special about SimBioSys is that the types of problems we are tackling make a positive impact on peoples’ lives. That is surprisingly rare in this world. Many people, scientists included, can go their entire careers without ever producing anything that directly improves the lives of their friends, neighbors, and loved ones. I feel fortunate to have that opportunity. Its what gets me out of bed in the morning, and its what drives me to continuously push the envelope of what we know about cancer. The more we understand, the more effectively we can treat patients, and the better and richer all of our lives become.

Daniel Cook

I started cancer research because I want to help people. And I understand – to a limited extent – the uncertainty and confusion that comes when you or a loved one is diagnosed with a chronic or terminal illness. Two of the first things that come to mind for me are “Can this just go away?” and “What happens now?” At SimBioSys, the work I do empowers patients with precision prognosis and empowers doctors to choose the best possible treatment for each patient. So the answers to those questions are “Yes, the cancer can go away” and “What happens now is, you get better.”

One of the most exciting things I work on is exploring how patients can use precise interventions in diet, exercise, and complementary therapies to support their body during chemotherapy, increasing chemotherapy effectiveness in killing the tumor while reducing toxicity to the rest of the body.

Tyler Earnest

Coming from a background in computational physics, I never expected to use my training directly to make an impact on people’s lives. I feel incredibly privileged to have the opportunity to transform basic research in computational biophysics into tools used at the point of care to help heal those stricken with cancer.

John Pfeiffer

Breast cancer is the most commonly diagnosed cancer across the US and the world, and the biological underpinnings of the disease are incredibly heterogeneous. Identifying peripheral biomarkers of other diseases in my thesis work has prepared me to investigate the underlying heterogeneity in breast cancer and to operate at the challenging, bleeding-edge of scientific innovation. SimBioSys has provided me the opportunity to head home at the end of the day knowing that I spent my time and effort towards making the world a better place, while tackling the challenges of breast cancer head on.

Gregory Norris

When I started my career in academic research, I decided that science was meant to help people. Still feeling like I could be doing more, I became a data scientist. Pivoting over to data science led me to a whole new set of challenges but my goal of helping people became muddled. When I became aware of SimBioSys, I was drawn in by the opportunity to combine biological science and data science. I’m here now because SimBioSys gives me an opportunity to work on new challenging problems with a clear vision of helping people and the amount of learning I can do simply by osmosis from the people around me. I don’t think it can get much better than that.

Yuhan Zhang

I always knew I would pursue a career in health. Since I missed the opportunity of becoming a doctor, I have been involved in public health and working with population health data. The beauty of using data science to answer health questions really makes me excited and I find it also so important as everyone could be connected with each other in the work like this. I really appreciate what people do at SimBioSys and I am so happy to join this family. We are piecing together patients’ information to complete the puzzle of cancer. “We write codes to change the life of patients.” — is there anything cooler than this?

Nicole Hobbs

I chose to work in computational drug modeling at SimBioSys so we can create a future where people with cancer are given personalized therapies with only medications we know their individual tumors will respond to. I wish TumorScope would have been available for my Grandpa who struggled with brain cancer and for whom some drugs did more harm than good. I believe the hard work we do every day will help a lot of people like him.

Kate Ritchie

My dad was a mechanic when he was my age. He used pressure gauges and sensors to figure out what was wrong with cars before he fixed them. Autoimmune diseases run in my family, and whenever anyone gets sick he complains and wishes he could ‘pop the hood’ on their immune system/metabolism and figure out what’s wrong. Unfortunately, diseases are a lot more complicated than cars. And it’s a horrible feeling not to understand why your body, or the body of someone you love, isn’t working. At SimBioSys, we’re using standard-of-care data to build those complex, sensitive gauges and sensors. I love that patients, their families, and their doctors are going to be able to see more clearly what’s gone wrong, and build a roadmap for how to get better.

Joseph R. Peterson

Vast improvements in technology over the last twenty years are poised to transform healthcare. Democratized and decentralized supercomputing, ever more common and accurate biodiagnostics, and the astonishing rate of algorithmic advances in both AI and physical simulations are going to make personalized medicine a reality. Working with teams at the intersection of these areas here at SimBioSys is a pleasure and an honor. Watching the innovation of our team in each of these areas on a day-to-day basis gives me the confidence that we will be able to make a meaningful impact in patients’ lives, and healthcare more broadly.

Arda Pekis

I am here to solve the hardest problem in the world.

Nicole Liadis

Losing friends and family to cancer has been heartbreaking and as a cancer researcher, the uncertainty of a cancer diagnosis for a patient has been discouraging. I was inspired to join the team at SimBioSys because I was dissatisfied with the present risks of cancer, and I believed that innovative technology at SimBioSys could create real and lasting changes. These changes will impact the future direction of personalized medicine, empowering cancer patients and transforming clinical decision making. Our technology goes beyond traditional radiomic and -omics data analyses, and provides the ability capture tumor biology and heterogeneity, optimizing patient-specific outcomes.

Dorys Lopez

At SimBioSys the focus every day is on the patients. That’s why I love coming to work every day, because I know that what we do has the potential to change patient’s lives for the better.